Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Robert D. Vilsack, serving as both Secretary and Chief Legal Officer at PARK OHIO HOLDINGS CORP (NASDAQ:PKOH), executed a sale of company equity on June 30, 2026. The transaction involved the disposal of 568 shares at a price point of $38.40 per share, resulting in a total transaction value of $21,811. This sale activity occurs as the company navig…
Vicor Corp (NASDAQ:VICR) Chairman and CEO Patrizio Vinciarelli completed a transaction involving the sale of 20,000 common shares on July 2, 2026, generating approximately $6.38 million. The sales were executed under a Rule 10b5-1 trading plan established on February 26, 2026. This transaction occurs amid significant stock volatility, with shares d…
Timothy Archer, President and CEO of Lam Research Corp, has executed a significant stock transaction involving the sale of 30,000 shares valued at approximately $11.7 million. The sale was conducted under a Rule 10b5-1 trading plan established earlier in 2026. This transaction occurs against a backdrop of analyst price target adjustments and ongoin…
Vicor Corp (NASDAQ:VICR) reported that Philip D. Davies, the company's Corporate Vice President of Global Sales & Marketing, executed a series of transactions on July 1, 2026. The executive disposed of approximately $1.1 million worth of company stock through a pre-arranged trading plan while simultaneously exercising non-qualified stock options to…
Kelly Roland Thomas, serving as Chief Legal Officer and General Counsel at Velocity Financial, Inc. (NASDAQ:VEL), executed a sale of company equity on July 1, 2026. The transaction involved the divestment of 1,600 shares of common stock, resulting in proceeds totaling $29,709. This sale activity occurs as Velocity Financial approaches its upcoming …
Horizon Kinetics Asset Management LLC, the investment adviser for RENN Fund, Inc., has expanded its direct ownership in the company by purchasing 756 additional shares on July 2, 2026. The transaction, valued at $2,351, brings the total direct holding to 929,640 shares. This move occurs as RENN Fund trades at $3.01 per share, reflecting a 14.5% ret…
Vicor Corp (NASDAQ:VICR) Chairman and Chief Executive Officer Patrizio Vinciarelli executed a substantial transaction on July 1, 2026, disposing of 19,540 shares of common stock for approximately $7.13 million. The sales were facilitated through a Rule 10b5-1 trading plan established on February 26, 2026. The execution of this sale follows a period…
Joseph Stilwell and his affiliated investment entities have significantly increased their holdings in Peoples Financial Corp. (NASDAQ:PFBX). Recent filings indicate a series of purchases totaling $56,461 executed in early July 2026. This activity occurs as the stock trades near its 52-week peak, with valuation metrics suggesting the shares may be p…
Labcorp Holdings Inc. (NASDAQ:LH) Executive Vice President and Chief Legal Officer Kathryn W. Kyle executed a series of transactions involving the company's common stock in early July 2026. The activity includes the sale of 92 shares valued at $26,329 under a Rule 10b5-1 trading plan, alongside the vesting of Restricted Stock Units and the subseque…
Bryan T. Vaughn, Executive Vice President and President of Diagnostics at Labcorp Holdings Inc., executed a series of stock transactions in early July 2026. The executive sold 234 shares at $286.19 per share, totaling approximately $66,968, through a Rule 10b5-1 trading plan. This sale occurred as Labcorp's stock traded near its 52-week high of $29…
Francisco Trust, a significant shareholder in Dyadic International (NASDAQ:DYAI), has executed a series of share sales totaling $343,763 across a period extending from June 2024 to January 2025. This divestment reduces the trust's direct holdings while the company navigates complex financial instruments, including an amended senior secured converti…
A-6684 Ltd., recognized as a 10% beneficial owner of Tofutti Brands Inc. (NASDAQ: TOFB), has executed a new purchase of the company's common stock. The transaction, reported on July 2, 2026, involves the acquisition of 3,936 shares valued at $2,557. This move increases the entity's indirect holdings in the plant-based food manufacturer, which curre…
Spyre Therapeutics (NASDAQ: SYRE) Chief Financial Officer Scott L. Burrows executed a series of share sales totaling $658,039 on July 1, 2026, following the exercise of stock options. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan established in November 2025. This financial activity occurs as the company navigates a …
Lightspeed Management Company, L.L.C. has completed the sale of its entire direct stake in Navan, Inc. (NAVN), liquidating 10,569 shares for approximately $260,525 on July 1, 2026. The transaction occurred as NAVN stock traded between $24.58 and $24.71, following a period where the share price reached a 52-week high of $25.86. While the management …
Investment vehicles linked to Lightspeed Venture Partners, which collectively hold a 10% stake in Navan, Inc. (NASDAQ: NAVN), executed a sale of 10,569 Class A common shares on July 1, 2026. The transaction, processed by Lightspeed Management Company, L.L.C., realized approximately $260,525 at a weighted average price of $24.65 per share. The sale …
Sheldon Sloan, the Chief Medical Officer at Spyre Therapeutics, Inc. (NASDAQ:SYRE), executed a comprehensive divestiture of his equity position, selling 8,334 shares for a total of $730,895 on July 1, 2026. The transaction involved the exercise of stock options at $27.46 per share followed by immediate sales at prices ranging from $87.03 to $88.95.…
Spyre Therapeutics CEO Cameron Turtle executed a series of stock sales totaling approximately $1.32 million in early July 2026. The transactions occurred against a backdrop of significant stock appreciation and positive clinical trial updates for the company's ulcerative colitis candidate. Turtle's sales were conducted under a pre-existing trading …
CoreWeave, Inc. (CRWV) Chief Strategy Officer Brian Venturo executed a series of share transactions totaling approximately $12.9 million in late June and early July 2026. The moves include direct sales to cover tax liabilities from restricted stock unit settlements and indirect sales through affiliated entities operating under a pre-arranged 10b5-1…
Kristen J McVeety, serving as General Counsel and Secretary for CoreWeave, Inc. (NASDAQ:CRWV), executed a sale of 4 shares of the company’s Class A Common Stock on June 30, 2026. The transaction, valued at $382, occurred at a price of $95.69 per share. This sale was necessitated by tax withholding obligations linked to the vesting and settlement of…
CoreWeave, Inc. (NASDAQ:CRWV) CEO Michael N. Intrator executed a significant divestment of company equity, offloading approximately $37.7 million in Class A Common Stock on June 30, 2026. This transaction, reported through an SEC Form 4 filing, involves a mix of direct sales and indirect transactions through Omnadora Capital LLC. While a portion of…
CoreWeave EVP Goldberg Chen sold a small portion of his holdings on June 30, 2026, while simultaneously acquiring shares from restricted stock unit settlements. The transaction occurs against a backdrop of significant stock price declines and ongoing strategic developments within the company, including the launch of a new AI research agent and comp…
Sachin Jain, Chief Operating Officer of CoreWeave, Inc. (NASDAQ:CRWV), executed a series of stock transactions on June 30, 2026, selling three shares of Class A Common Stock at $95.69 per share. The sale was processed to cover tax withholding obligations associated with the vesting of restricted stock units. Concurrently, Jain acquired seven shares…
CoreWeave, Inc. (NASDAQ:CRWV) Chief Financial Officer Nitin Agrawal executed a transaction on June 30, 2026, selling four shares of the company's Class A Common Stock. The sale, valued at $382, was conducted to meet tax withholding requirements related to the vesting and settlement of restricted stock units. This transaction occurred as CoreWeave's…
Jeff Baker, CoreWeave's principal accounting officer, executed a minor stock sale on June 30, 2026, to satisfy tax liabilities from vesting restricted stock units. The transaction occurred against a backdrop of significant stock depreciation, with shares falling over 15% in a week and more than 50% year-over-year. Concurrently, the company is manag…
Procore Technologies, Inc. (NASDAQ: PCOR) director Kevin J. O’Connor has executed a series of stock sales totaling $488,902 through a pre-established Rule 10b5-1 trading plan. The transactions, which occurred on July 1 and July 2, 2026, were conducted indirectly via the Kevin J. O’Connor Revocable Trust. This insider activity unfolds against a back…
